obesity glp-1 news today The Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Drugs Patient Behavior: How Does Price

Men on TRT who want to maintain testicular function and fertility

Tapered conical polymer microneedles fabricated using an integrated lens technique for transdermal drug delivery

10.1001/jamainternmed.2024.4369 Summary Keywords cardiovascular disease, cardiovascular outcome, glucagon-like peptide-1 receptor agonists, heart failure, obesity Citation Turkistani Y (2025) Glucagon-like peptide-1 receptor agonists: a review from a cardiovascular perspective

A growing body of evidence suggests that these conditions are characterized by severe, systemic mitochondrial dysfunction

While some experience minimal discomfort, others find the initial weeks challenging as their body adjusts to the medication